N. Andreasen

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

H. Arai, K. Blennow, H. Hampel, 2002, Neurology.

Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease

K. Blennow, H. Vanderstichele, D. Small, 2003, Journal of neuroscience research.

Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI

K. Blennow, P. Scheltens, H. Hampel, 2007, Neurology.

CSF Biomarkers for Alzheimer’s Disease: Levels of β-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival

K. Blennow, L. Minthon, Å. Wallin, 2006, Dementia and Geriatric Cognitive Disorders.

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease

K. Blennow, G. Waldemar, L. Minthon, 2008, Neurobiology of Aging.